Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-10-30

Clinical Trial Update: Clinical Study of Caffeine for Apnea of Prematurity [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating caffeine citrate for apnea of prematurity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Caffeine citrate (caffeine citrate)

Snippet

Sponsor: Nobelpharma | Conditions: Apnea of Prematurity | Phase 3 | Status: COMPLETED